Navigating the Brain-Computer Interface Frontier: An Interview with ex-NASA Expert
In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of … Read More
Where Tech Meets Bio
Popular articles
The Rise of Decentralized Clinical Trials: 10 Companies Pushing the Field Forward
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
Latest Insights
Beyond Neuralink: The Diverse Landscape of Brain-Computer Interfaces
A Growing Race to Change Status Quo in the Lucrative NGS Market
A Booming Anti-Obesity Drug Discovery Landscape at a Glance (With Challenges)
21 Life Science Marketplaces to Try in 2024
14 Companies Pioneering AI Foundation Models in Pharma and Biotech
This Company Anonymized 1.8 Trillion Records to Support Biomedical Research
Latest News
Light-weight Microscope Captures Large-scale Brain Activity in Freely Moving Mice
Aptamer Group Partners with AstraZeneca to Explore Optimer Vehicles for siRNA Delivery
Latest News
Synchron Integrates Generative AI with Brain-Computer Interface Software
Oxford Drug Design Validates Novel Oncology Therapeutic Mechanism
Bioptimus Introduces H-optimus-0: An Open-Source AI Model for Pathology
Gene-Editing Tool Modifies Gut Bacteria in Living Mice
Lantern Pharma Advances Development of Molecular Diagnostic for Oncology Clinical Trials
Concr Launches VISION Trial Using Digital Twins for Predicting Breast Cancer Outcomes
Advances in LBP Manufacturing: Microbiotica and Biose Industrie Prepare for Clinical Studies
Columnists
Transformational EGFR Drug Discovery
by Chris De Savi
7 Tips for Growing a Successful ‘AI in Pharma’ Business: Ke…
by Amandeep Singh
Some Drugs That Improve Price Competition Fall Through The …
by Isaac Smith
Life Sciences & Net Zero: Charting a Sustainable Path
by Michael Whitworth
From Our Partners
AI Breaches the Barrier Towards Better CNS Drug Discovery
How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery
by Syntekabio
How to Discover a Preclinical Drug Candidate in Two Years
by Syntekabio
How AI Empowers Biomarker-Driven Clinical Trials
Partner Events
21st biopharma Clinical Trials Nexus Conference
Event Date: Oct. 22, 2024 - Oct. 23, 2024
Location: United States of America (Princeton, New Jersey)
Website: Link
The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 26, 2024 - Aug. 30, 2024
Location: Denmark (Ceremonial Hall, University of Copenhagen Frue Plads 4, 1165 København)
Website: Visit ARDD 2024
BioTech Scout
Case Studies
Cyclica's Chemical Probes for DCAF1
Sponsored by Cyclica
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by Lantern Pharma
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by Biocompare
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by RECEPTOR.AI
Interviews
[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering
From Data to Treatment: Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials
Most Read
The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing
Top AI in Pharma & Healthcare Conferences in 2022 You Can’t Miss
14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)
A Market Review of DNA-encoded Libraries Technology in Drug Discovery